RET and medullary thyroid gland carcinoma: Importantly our data suggest that medullary thyroid cancer onset in moderate-risk RET variant carriers occurs predominantly in adulthood in genotype-first and even in phenotype-first approaches (with 100% and 84% developing medullary thyroid cancer after age 30 years, respectively).